Organic & Biomolecular Chemistry
Page 6 of 10
130.2, 130.1, 130.0, 90.3, 73.1, 72.5, 70.5, 70.1, 21.2, 0.23 (3C),
0.16 (3C). ESIꢀMS; 448 (M+Na)+;
Anal. Cal. for
1
1.0, CHCl3). H NMR (500 MHz, CDCl3), δ; 5.98 (bs, 1H), 4.60
(dd, J = 3.3, 6.8 Hz, 1H), 4.49 (d, J = 6.8 Hz, 1H), 3.95ꢀ3.93 (m,
1H), 3.88 (dd, J = 3.2, 8.9 Hz, 1H), 3.27 (dd, J = 2.5, 12.7 Hz,
1H, Hꢀ6a/b), 3.11 (dd, J = 5.0, 12.7 Hz, 1H, Hꢀ6a/b), 1.87 (s, 3H),
C17H29N3O3SSi2; C, 50.79; H, 7.34; N, 9.87; Found C, 50.34; H,
7.24; N, 9.70.
5
1.28 (s, 3H), 1.09 (s, 3H), ꢀ0.006 (s, 9H). 13C NMR (50 MHz, 65 Methyl
5-azido-5-deoxy-2,3-di-O-trimethylsily-α-D-
CDCl3), δ; 169.2, 112.7, 101.2, 84.7, 81.5, 78.9, 68.9, 54.8, 25.9,
24.6, 21.6, 0.23 (3C). ESIꢀMS; 382 (M+Na)+; Anal. Cal. for
C14H25N3O6Si; C, 46.78; H, 7.01; N, 11.69; Found C, 46.57; H,
6.92; N, 11.53.
ribofuranoside (10a). Prepared by the general procedure 2 using
1.0 mmol (192 mg) of 10 to yield the desired product 10a (81%,
292 mg) as oily liquid. IR (CHCl3): 2954, 2106, 1255, 1056, 844
cmꢀ1. [α]20 = +37.0 (c, 1.0, CHCl3). 1H NMR (500 MHz,
D
10 Methyl
4,6-O-benzylidene-2,3-di-O-trimethylsilyl-α-
D
-
70 CDCl3), δ; 3.90 (t, J = 3.3, 1H), 3.62 (dd, J = 5.3, 11.6, 1H), 3.65ꢀ
3.63 (m, 1H), 3.35 (s, 3H), 3.07 (d, J = 4.0 Hz, 1H), 3.06 (dd, J =
11.5, 13.6 Hz, 1H, Hꢀ6a/b), 3.03 (dd, J = 4.0, 11.5 Hz, 1H, Hꢀ
6a/b), ꢀ0.015 (s, 9H), ꢀ0.044 (s, 9H). 13CNMR (50 MHz, CDCl3),
δ; 104.7, 73.4, 70.6, 69.3, 66.6, 56.8, 0.29 (3C), 0.14 (3C). ESIꢀ
glucopyranoside (6a). Prepared by the general procedure 1 using
1.0 mmol (282 mg) of 6 to yield the desired product 6a (72%,
306 mg) as oily liquid. IR (CHCl3): 3034, 2997, 1290, 1058cmꢀ1.
1H NMR (500 MHz, CDCl3), δ; 7.32ꢀ7.30 (m, 2H), 7.20ꢀ7.16 (m,
15 3H), 5.33 (s, 1H), 4.45 (d, J = 3.7 Hz, 1H), 4.09 (dd, J = 4.7, 10.4 75 MS; 384 (M+Na)+. Anal. Cal. For C12H27N3O4Si2; C, 43.21; H,
Hz, 1H), 3.78 (t, J = 8.9 Hz, 1H), 3.63ꢀ3.61 (m, 1H), 3.53 (t, J =
10.2 Hz, 1H), 3.44 (dd, J = 3.7, 8.7 Hz, 1 H), 3.25 (s, 3H), 3.23ꢀ
3.21 (m, 1H), ꢀ0.01 (s, 9H), ꢀ0.07 (s, 9H). 13C NMR (50 MHz,
CDCl3), δ; 137.0, 128.5, 128.4, 127.8, 127.7, 125.8, 101.3,
8.16; N, 12.60; Found C, 43.02; H, 8.03; N, 12.49.
Methyl 6-azido-6-deoxy-2,3,4-tri-O-trimethylsilyl-α-
glucopyranoside (11a). Prepared by the general procedure 3
using 1.0 mmol, (194 mg) of 11 to yield the desired product 11a
D-
20 100.6, 81.7, 73.8, 71.4, 68.7, 62.0, 55.0, 0.5 (3C), 0.3 (3C). ESIꢀ 80 (90%, 391 mg) as oily liquid. IR (CHCl3): 2958, 2099, 1253,
MS; 449 (M+Na)+; Anal. Cal. For C21H36O5Si2; C, 56.30; H,
8.03; Found C, 56.21; H, 7.91.
1057, 845cmꢀ1. [α]20 = +68.0 (c, 1.0, CHCl3). 1H NMR (500
D
MHz, CDCl3), δ; 4.46 (d, J = 3.6 Hz, 1H), 3.56ꢀ3.55 (m, 1H),
3.52 (dd, J = 2.4, 6.4 Hz, 1H), 3.32 (dd, J = 3.6, 13.2 Hz, 1H),
3.28 (dd, J = 2.4, 13.2 Hz, 1H), 3.24 (dd, J = 6.0, 9.6 Hz, 1H, Hꢀ
85 6a/b), 3.21 (s, 3H, ꢀOCH3), 3.17 (dd, J = 6.0, 13.2 Hz, 1H, Hꢀ
6a/b), 0.029 (s, 9H), ꢀ0.014 (s, 9H), ꢀ0.027 (s, 9H). 13C NMR (50
MHz, CDCl3), δ; 99.8, 74.8, 73.7, 73.0, 70.8, 54.5, 51.6, 0.98
(3C), 0.94 (3C), 0.68 (3C). ESIꢀMS; 458 (M+Na)+ ; Anal. Cal.
for C16H37N3O5Si3 ; C, 44.10; H, 8.56; N, 9.64. Found C, 39.92;
90 H, 8.43; N, 9.53.
Methyl 6-Azido-2,3-di-O-benzyl-6-deoxy-4-O-trimethylsilyl-α-
D-glucopyranoside (7a). Prepared by the general procedure 2
25 using 1.0mmol (374 mg) of 7 to yield the desired product 7a
(89%, 419 mg) as oily liquid. IR (CHCl3): 3032, 2098, 1252,
1053, 842cmꢀ1. [α]20 = +55.0 (c, 1.0, CHCl3). 1H NMR (400
D
MHz, CDCl3), δ; 7.26ꢀ7.34 (m, 10H), 4.99 (d, J = 11.2 Hz, 1H),
4.73 (d, J = 11.2 Hz, 1H), 4.68 (bs, 1H), 4.59 (d, J = 2.0 Hz, 1H),
30 4.58 (d, J = 10.4 Hz, 1H), 3.75ꢀ3.70 (m, 2H), 3.54 (d, J = 9.2 Hz,
1H), 3.49 (dd, J = 3.6, 9.6 Hz, 1H), 3.45 (dd, J = 2.4, 12.8 Hz,
1H, Hꢀ6a/b), 3.39 (s, 3H, ꢀOCH3), 3.33 (dd, J = 5.6 12.8 Hz, 1H,
Hꢀ6a/b), 0.094 (s, 9H). 13C NMR (50 MHz, CDCl3), δ; 138.3,
137.4, 127.8, 127.7, 127.6, 127.5, 127.4, 127.3, 126.9, 126.7,
35 126.6, 126.5, 97.3, 80.8, 79.6, 74.7, 72.7, 71.1, 70.4, 54.7, 50.7, ꢀ
0.23 (3C). ESIꢀMS; 494 (M+Na)+; Anal. Cal. for C24H33N3O5Si;
C, 61.12; H, 7.05; N, 8.91; Found C, 61.02; H, 6.93; N, 8.70.
6-Azido-6-deoxy-l,2-O-(l-methyIethyIidene)-3,5-di-O-
Benzyl
6-azido-6-deoxy-2,3,4-tri-O-trimethylsilyl-α-D-
mannopyranoside (12a). Prepared by the general procedure 3
using 1.0 mmol (270 mg) of 12 to yield the desired product 12a
(89%, 454 mg) as oily liquid. IR (CHCl3): 3035, 2956, 2100,
1
95 1250, 1099, 842cmꢀ1. [α]20 = +46.0 (c, 1.0, CHCl3). H NMR
D
(400 MHz, CDCl3); δ; 7.22ꢀ7.15 (m, 5H), 4.61 (d, J = 12.0 Hz,
1H), 4.54 (d, J = 1.6 Hz, 1H), 4.38 (d, J = 12 Hz, 1H), 3.7 (d, J =
9.2 Hz, 1H), 3.67 (dd, J = 2.4, 4.0 Hz, 1H), 3.63 (dd, J = 2.4, 10
Hz, 1H), 3.59ꢀ3.57 (m, 1H), 3.26 (dd, J = 2.4, 12.8 Hz, 1H, Hꢀ
100 6a/b), 3.19 (dd, J = 6.8, 12.8 Hz, 1H, Hꢀ6a/b), ꢀ0.009 (s, 9H), ꢀ
0.024 (s, 9H), ꢀ0.04 (s, 9H). 13C NMR (100 MHz, CDCl3),
δ; 137.2, 127.6, 127.5, 127.4, 126.2, 126.1, 99.5, 73.2, 73.1, 72.1,
68.8, 68.5, 51.1, 0.46 (3C), 0.37 (3C), 0.34 (3C). ESIꢀMS; 534
(M+Na)+; Anal. Cal. for C22H41N3O5Si3; C, 51.63; H, 8.07; N,
105 8.21; Found C, 51.34; H, 7.89; N, 8.01.
trimethylsilyl-α-D-glucofuranose (8a). Prepared by the general
40 procedure 2 using 1.0 mmol (220 mg) of 8 to yield the desired
product 8a (95%, 369 mg) as oily liquid. IR (CHCl3): 2962, 2100,
1
1253, 1058, 843 cmꢀ1. [α]20 = ꢀ15.0 (c, 1.0, CHCl3). H NMR
D
(400MHz, CDCl3), δ; 5.84 (d, J = 3.6 Hz, 1H), 4.40 (d, J = 3.6
Hz, 1H), 4.20 (d, J = 2.0 Hz, 1H), 4.10ꢀ4.04 (m, 2H), 3.55 (dd, J
45 = 5.2, 12.4 Hz, 1H, Hꢀ6a/b), 3.42 (dd, J = 5.2, 8.0 Hz, 1H, Hꢀ
6a/b), 1.47 (s, 3H), 1.30 (s, 3H), 0.185 (s, 9H), 0.176 (s, 9H). 13
C
NMR (50 MHz, CDCl3), δ; 111.9, 104.9, 84.4, 81.6, 75.2, 68.8,
54.9, 26.7, 26.3, 0.61 (3C), 0.46 (3C). ESIꢀMS; 412 (M+Na)+;
Anal. Cal. for C15H31N3O5Si2; C, 46.24; H, 8.02; N, 10.79; Found
50 C, 46.11; H, 7.93; N, 10.70.
Methyl
6-azido-6-deoxy-2,3,4-tri-O-trimethylsilyl-α-D-
mannopyranoside (13a). Prepared by the general procedure 3
using 1.0 (194 mg) of 13 to yield the desired product 13a (90%,
391 mg) as oily liquid. IR (CHCl3): 2958, 2914, 2099, 1252,
110 1154, 1020, 840, 752 cmꢀ1. [α]20 = +73.0 (c, 1.0, CHCl3). H
1
Thio-p-toluoyl
5-azido-5-deoxy-2,3-di-O-trimethylsily-β-D-
D
ribofuranoside (9a). Prepared by the general procedure 2 using
1.0 mmol (256 mg) of 9 to yield the desired product 9a (82%,
NMR (500 MHz, CDCl3), δ; 4.34 (bs, 1H), 3.68 (t, J = 9.0 Hz,
1H), 3.63 (d, J = 1.5 Hz, 1H), 3.57 (dd, J = 2.5, 8.8 Hz, 1H),
3.51ꢀ3.50 (m, 1H), 3.28 (dd, J = 2.1, 12.8 Hz, 1H, Hꢀ6a/b), 3.23
(s, 3H, ꢀOCH3), 3.19 (dd, J = 7.1, 12.8 Hz, 1H, Hꢀ6a/b), ꢀ0.021 (s,
115 9H), ꢀ0.034 (s, 9H), ꢀ0.096 (s, 9H). 13C NMR (50 MHz, CDCl3),
δ; 101.4, 73.04, 73.02, 72.03, 68.7, 54.4, 51.0, 0.38 (3C), 0.24
(3C), 0.15 (3C). ESIꢀMS; 458 (M+Na)+; Anal. Cal. for
C16H37N3O5Si3; C, 44.10; H, 8.56; N, 9.64; Found C, 44.01; H,
348 mg) as oily liquid. IR (CHCl3): 3034, 2957, 2108, 1253,
1
55 1088, 843cmꢀ1. [α]20 = = +43.0 (c, 1.0, CHCl3). H NMR (500
D
MHz, CDCl3), δ; 7.22ꢀ7.19 (m, 2H), 6.97ꢀ6.92 (m, 2H), 4.28 (d, J
= 9.1 Hz, 1H), 3.71 (dd, J = 5.2, 11.4 Hz, 1H), 3.45ꢀ3.43 (m, 1H),
3.35ꢀ3.33 (m, 1H), 3.09 (dd, J = 10.4, 16.1Hz, 1H, Hꢀ5a/b), 3.01
(dd, J = 10.4, 11.4 Hz, 1H, Hꢀ5a/b), 2.16 (s, 3H), 0.04 (s, 9H),
60 0.006 (s, 9H). 13C NMR (50MHz, CDCl3), δ; 137.8, 132.7, 132.6,
6
| Journal Name, [year], [vol], 00–00
This journal is © The Royal Society of Chemistry [year]